REFERENCES
- Koren M J, Devereux R B, Casale P N, Savage D D, Laragh J H. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med. 1991; 114: 345–352, [PUBMED], [INFOTRIEVE], [CSA]
- Meerson F Z. The myocardium in hyperfunction, hypertrophy and heart failure. Circ Res. 1969; 25: 1–163, Suppl, 2[PUBMED], [INFOTRIEVE], [CSA]
- Morgan H E, Baker K M. Cardiac hypertrophy: mechanical, neural and endocrine dependence. Circulation. 1991; 83: 13–25, [PUBMED], [INFOTRIEVE], [CSA]
- Schaub M C, Hefti M A, Harder B A, Eppenberger H M. Various hypertrophic stimuli induce distinct phenotypes in cardiomyocytes. J Mol Med. 1997; 75: 901–920, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Weber K T, Brilla C G. Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system. Circulation. 1991; 83: 1849–1865, [PUBMED], [INFOTRIEVE], [CSA]
- Anversa P, Kajstura J, Olivetti G. Myocyte death in heart failure. Curr Opin Cardiol. 1996; 11: 245–251, [PUBMED], [INFOTRIEVE], [CSA]
- Swynghedauw B. Left ventricular remodeling. A complex biological problem around three simple paradigms. Bull Acad Natl Med. 1998; 182: 665–682, [PUBMED], [INFOTRIEVE], [CSA]
- Colucci W S. Molecular and cellular mechanisms of myocardial failure. Am J Cardiol. 1997; 80: 15L–25L, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Bishop J E. Regulation of cardiovascular collagen deposition by mechanical forces. Mol Med Today. 1998; 4: 69–75, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Lorell B H. Transition from hypertrophy to failure. Circulation. 1997; 96: 3824–3827, [PUBMED], [INFOTRIEVE], [CSA]
- Abassi Z A, Kelly G, Golomb E, Klein H, Keiser H R. Losartan improves the natriuretic response to ANF in rats with high-output heart failure. J Pharmacol Exp Ther. 1994; 268: 224–230, [PUBMED], [INFOTRIEVE], [CSA]
- Abassi Z A, Brodsky S, Karram T, Dobkin I, Winaver J, Hoffman A. Temporal changes in natriuretic and antinatriuretic systems after closure of a large arteriovenous fistula. Cardiovasc Res. 2001; 51: 567–576, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Pieruzzi F, Abassi Z A, Keiser H R. Expression of renin-angiotensin system components in the heart, kidneys, and lungs of rats with experimental heart failure. Circulation. 1995; 92: 3105–3112, [PUBMED], [INFOTRIEVE], [CSA]
- Zhu Y -C, Zhu Y -Z, Gohlke P, Stauss H M, Unger T. Effects of angiotensin-converting enzyme inhibition and angiotensin II AT1 receptor antagonism on cardiac parameters in left ventricular hypertrophy. Am J Cardiol. 1997; 80: 110A–117A, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Wollert K C, Drexler H. The renin-angiotensin system and experimental heart failure. Cardiovasc Res. 1999; 43: 838–849, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Butt R P, Laurent G J, Bishop J E. Mechanical load and polypeptide growth factors stimulate cardiac fibroblast activity. Ann NY Acad Sci. 1995; 752: 387–393, [PUBMED], [INFOTRIEVE], [CSA]
- Paradis P, Dali-Youcef N, Paradis F W, Thibault G, Nemer M. Overexpression of angiotensin II type I receptor in cardiomyocytes induces cardiac hypertrophy and remodeling. Proc Natl Acad Sci USA. 2000; 97: 931–936, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Duchman S M, Thohan V, Karla D, Torre-Amione G. Endothelin-1: A new target of therapeutic intervention for the the treatment of heart failure. Curr Opin Cardiol. 2000; 15: 136–140, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Thürmann P A, Kenedi P, Schmidt A, Harder S, Rietbrock N. Influence of the angiotensin II antagonist valsartan on left ventricular hypertrophy in patients with essential hypertension. Circulation. 1998; 98: 2037–2042, [CSA]
- Drewett J G, Garbers D L. The family of guanylyl cyclase receptors and their ligands. Endocr Rev. 1994; 15: 135–162, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Yamamoto K, Burnett J C, Jr, Jougasaki M, Nishimura R A, Bailey K R, Saito Y, Nakao K, Redfield M M. Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy. Hypertension. 1996; 28: 988–994, [PUBMED], [INFOTRIEVE], [CSA]
- Moe G W, Grima E A, Wong N LM, Howard R J, Armstrong P W. Dual natriuretic peptide system in experimental heart failure. J Am Coll Cardiol 1993; 22: 891–898, [PUBMED], [INFOTRIEVE], [CSA]
- Stumpe K, Solle H, Klein H, Kruck F. Mechanism of sodium and water retention in rats with experimental heart failure. Kidney Int. 1973; 4: 309–317, [PUBMED], [INFOTRIEVE], [CSA]
- Isgaard J, Wahlander H, Adams M A, Friberg P. Increased expression of growth hormone receptor mRNA and insulin-like growth factor-I mRNA in volume-overloaded hearts. Hypertension. 1994; 23: 884–888, [PUBMED], [INFOTRIEVE], [CSA]
- Langenickel T, Pagel I, Hohnel K, Dietz R, Willenbrock R. Differential regulation of cardiac ANP and BNP mRNA in different stages of experimental heart failure. Am J Physiol. 2000; 278: H1500–H1506, [CSA]
- Nishikimi T, Horio T, Sasaki T, Yoshihara F, Takishita S, Miyata A, Matsuo H, Kangawa K. Cardiac production and secretion of adrenomedullin are increased in heart failure. Hypertension. 1997; 30: 1369–1375, [PUBMED], [INFOTRIEVE], [CSA]
- Abassi Z, Gurbanov K, Rubinstein I, Better O S, Hoffman A, Winaver J. Regulation of intrarenal blood flow in experimental heart failure: Role of endothelin and nitric oxide. Am J Physiol. 1998; 274: F766–774, [PUBMED], [INFOTRIEVE], [CSA]
- Abassi Z, Francis B, Wessale J, Ovcharenko E, Winaver J, Hoffman A. Effects of endothelin receptors ETA and ETB blockade on renal haemodynamics in normal rats and in rats with experimental congestive heart failure. Clin Sci. 2002; 103: 245S–248S, [PUBMED], [INFOTRIEVE], [CSA]
- Iwai N, Shimoike H, Kinoshita M. Cardiac renin-angiotensin system in the hypertrophied heart. Circulation. 1995; 92: 2690–2696, [PUBMED], [INFOTRIEVE], [CSA]
- Tanaka N, Ryoke T, Hongo M, Mao L, Rockman H A, Clark R G, Ross J. Jr. Effects of growth hormone and IGF-I on cardiac hypertrophy and gene expression in mice. Am J Physiol. 1998; 275: H393–H399, [PUBMED], [INFOTRIEVE], [CSA]
- Guzman R J, Krystkowiak A, Zarins C K. Early and sustained medial cell activation after aortocaval fistula creation in the mouse. J Surg Res. 2002; 108: 112–121, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Scheuermann-Freestone M, Simon-Freestone N, Langenickel T, Hohnel K, Dietz R, Willenbrock R. A new model of chronic congestive heart failure in the mouse due to chronic volume overload. Eur J Heart Fail. 2001; 3: 535–543, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987; 162: 156–159, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Yanagisawa H, Yanagisawa M, Kapur R P, Richardson J A, Williams S C, Clouthier D E, de Wit D, Emoto N, Hammer R E. Dual genetic pathways of endothelin-mediated intercellular signaling revealed by targeted disruption of endothelin converting enzyme-1 gene. Development. 1998; 125: 825–836, [PUBMED], [INFOTRIEVE], [CSA]
- Tanaka N, Dalton N, Rockman H A, Peterson K L, Hunter J J, Chien K R, Ross J. Jr. Transthoracic echocardiography in the normal and abnormal mouse heart. Circulation. 1996; 94: 1109–1117, [PUBMED], [INFOTRIEVE], [CSA]
- Yorikane R, Sakai S, Miyauchi T, Sakurai T, Sugishita Y, Goto K. Increased production of endothelin-1 in the hypertrophied rat heart due to pressure overload. FEBS Lett. 1993; 332: 31–34, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Zolk O, Quattek J, Sitzler G, Schrader T, Nickenig G, Schnabel P, Shimada K, Takahashi M, Bohm M. Expression of endothelin-1, endothelin-converting enzyme, and endothelin receptors in chronic heart failure. Circulation. 1999; 99: 2118–2123, [PUBMED], [INFOTRIEVE], [CSA]
- Agapitov A V, Haynes W G. Role of endothelin in cardiovascular disease. J Renin Angiotensin Aldosterone Syst. 2002; 3: 1–15, [PUBMED], [INFOTRIEVE], [CSA]
- Kirchengast M, Munter K. Endothelin-1 and endothelin receptor antagonists in cardiovascular remodeling. Proc Soc Exp Biol Med. 1999; 221: 312–325, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Burnett J C, Jr, Kao P C, Hu D C, Heser D W, Heublein D, Granger J P, Opgenorth T J, Reeder G S. Atrial natriuretic peptide elevation in congestive heart failure in the human. Science 1986; 231: 1145–1147, [PUBMED], [INFOTRIEVE], [CSA]
- Mittmann C, Münstermann U, Weil J, Böhm M, Herzig S, Nienaber C, Eschenhagen T. Analysis of gene expression patterns in small amounts of human ventricular myocardium by a multiplex RNase protection assay. J Mol Med. 1998; 76: 133–140, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Hefti M A, Harder B A, Eppenberger H M, Schaub M C. Signaling pathways in cardiac myocyte hypertrophy. J Mol Cell Cardiol. 1997; 29: 2873–2892, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Avramovitch N, Hoffman A, Winaver J, Haramati A, Lewinson D. Morphometric analysis of atrial natriuretic peptide-containing granules in atriocytes of rats with experimental congestive heart failure. Cell Tissue Res. 1995; 279: 575–583, [PUBMED], [INFOTRIEVE], [CSA]
- Calderone A, Thaik C M, Takahashi N, Chang D LF, Colucci W S. Nitric oxide, atrial natriuretic peptide, and cyclic GMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes and fibroblasts. J Clin Invest. 1998; 101: 812–818, [PUBMED], [INFOTRIEVE], [CSA]
- Tamura N, Ogawa Y, Chusho H, Nakamura K, Nakao K, Suda M, Kasahara M, Hashimoto R, Katsuura G, Mukoyama M, Itoh H, Saito Y, Tanaka I, Otani H, Katsuki M, Nakao K. Cardiac fibrosis in mice lacking brain natriuretic peptide. Proc Natl Acad Sci USA. 2000; 97: 4239–4244, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Oliver P M, Fox J E, Kim R, Rockman H A, Kim H -S, Reddick R L, Pandey K N, Milgram S L, Smithies O, Maeda N. Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A. Proc Natl Acad Sci USA. 1997; 94: 14730–14735, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]